Cargando…

Expanding the landscape of TCR gene therapy targeting MAGE

Detalles Bibliográficos
Autores principales:	Mao, Zhiyuan, Lee, John K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Gene & Cell Therapy 2023
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10195836/ https://www.ncbi.nlm.nih.gov/pubmed/37215387 http://dx.doi.org/10.1016/j.omto.2023.04.004

Ejemplares similares

TCR Gene Transfer: MAGE-C2/HLA-A2 and MAGE-A3/HLA-DP4 Epitopes as Melanoma-Specific Immune Targets
por: Straetemans, Trudy, et al.
Publicado: (2012)

P71. Adoptive transfer of TCR gene-transduced lymphocytes targeting MAGE-A4 for refractory esophageal cancer
por: Shiku, H, et al.
Publicado: (2014)

Avidity optimization of a MAGE‐A1‐specific TCR with somatic hypermutation
por: Bassan, David, et al.
Publicado: (2021)

Targeting melanoma with immunoliposomes coupled to anti-MAGE A1 TCR-like single-chain antibody
por: Saeed, Mesha, et al.
Publicado: (2016)

Exploring TCR-like CAR-Engineered Lymphocyte Cytotoxicity against MAGE-A4
por: Alsalloum, Alaa, et al.
Publicado: (2023)

A simple spreadsheet-based, MIAME-supportive format for microarray data: MAGE-TAB
por: Rayner, Tim F, et al.
Publicado: (2006)

Newly developed pseudogout arthritis after therapy with MAGE-A4 directed TCR T cells responded to treatment with tocilizumab
por: Kim, Sang T., et al.
Publicado: (2021)

Personalized Armored TCR-Redirected T Cell Therapy for Liver/Organ Transplant with Recurrent Cancer
por: Hafezi, Morteza, et al.
Publicado: (2021)

MAGE-A protein and MAGE-A10 gene expressions in liver metastasis in patients with stomach cancer
por: Suzuki, S, et al.
Publicado: (2008)

Cancer biomarkers and targeted therapies
por: Shen, Zhiyuan
Publicado: (2013)

In vivo persistence of adoptively transferred TCR gene-transduced lymphocytes with anti-tumor reactivity in patients with MAGE-A4 expressing esophageal cancer
por: Ikeda, Hiroaki, et al.
Publicado: (2013)

Twisting tails exposed: the evidence for TCR conformational change
por: Levin, Susan E., et al.
Publicado: (2005)

TCR diversity – a universal cancer immunotherapy biomarker?
por: McNeel, Douglas G.
Publicado: (2016)

An innovative and affordable quantitative assessment of human TCR repertoire
por: Amoriello, Roberta, et al.
Publicado: (2020)

The changing landscape of expanded access to investigational drugs for patients with unmet medical needs: ethical implications
por: Bunnik, Eline M., et al.
Publicado: (2017)

Atomic-resolution view of complete TCR-CD3 revealed
por: Chai, Jijie
Publicado: (2020)

Expression of MAGE‐1 Gene by Esophageal Carcinomas
por: Toh, Yuji, et al.
Publicado: (1995)

Pathogenicity of the MAGE family
por: Li, Sanyan, et al.
Publicado: (2021)

In vivo enhancement of the MAGE-specific cellular immune response by a recombinant MAGE1-MAGE3-TBHSP70 tumor vaccine
por: Junwei, Wang, et al.
Publicado: (2016)

The Expanding Genetic Landscape of Charcot-Marie-Tooth Diseases (CMTs): An Indian Perspective
por: Sanghani, Nirav
Publicado: (2022)

Expression of melanoma antigen-encoding genes (MAGE) by common primers for MAGE-A1 to -A6 in colorectal carcinomas among Koreans.
por: Park, Myeng-Sun, et al.
Publicado: (2002)

Erratum to: In vivo enhancement of the MAGE-specific cellular immune response by a recombinant MAGE1-MAGE3-TBHSP70 tumor vaccine
por: Junwei, Wang, et al.
Publicado: (2017)

T Cells Expressing a TCR-Like Antibody Selected Against the Heteroclitic Variant of a Shared MAGE-A Epitope Do Not Recognise the Cognate Epitope
por: Saeed, Mesha, et al.
Publicado: (2020)

MAGE genes: Prognostic indicators in AL amyloidosis patients
por: Liu, Yang, et al.
Publicado: (2019)

Miltiwire proportional chambers MAGE spectrometer
por: Gusev, K E, et al.
Publicado: (2003)

Re-examination of MAGE-A3 as a T-cell Therapeutic Target
por: Martin, Aaron D., et al.
Publicado: (2021)

Expression of MAGE-1 and -3 genes and gene products in human hepatocellular carcinoma
por: Kariyama, K, et al.
Publicado: (1999)

Expanding the knowledge translation metaphor
por: Engebretsen, Eivind, et al.
Publicado: (2017)

Mare-MAGE curated reference database of fish mitochondrial genes
por: Kasmi, Yassine, et al.
Publicado: (2023)

Evolutionary History of the Cancer Immunity Antigen MAGE Gene Family
por: Katsura, Yukako, et al.
Publicado: (2011)

Expression of MAGE‐B Genes in Esophageal Squamous Cell Carcinoma
por: Nagashima, Hideki, et al.
Publicado: (2001)

T cells with gamma/delta T cell receptors (TCR) of intestinal type are preferentially expanded in TCR-alpha-deficient lpr mice
Publicado: (1995)

MAGE-Targeted Gold Nanoparticles for Ultrasound Imaging-Guided Phototherapy in Melanoma
por: Li, Xuelin, et al.
Publicado: (2020)

Expanding role for single‐pill combination drug therapy in the initial treatment of hypertension?
por: Li, Yanglong, et al.
Publicado: (2021)

Expanding the therapeutic landscape: ezetimibe as non-statin therapy for dyslipidemia
por: Lee, Jeongmin, et al.
Publicado: (2023)

Frequent MAGE Mutations in Human Melanoma
por: Caballero, Otavia L., et al.
Publicado: (2010)

CRMAGE: CRISPR Optimized MAGE Recombineering
por: Ronda, Carlotta, et al.
Publicado: (2016)

MAGE-A Antigens and Cancer Immunotherapy
por: Zajac, Paul, et al.
Publicado: (2017)

Cancer/Testis Antigen MAGE-C1/CT7: New Target for Multiple Myeloma Therapy
por: de Carvalho, Fabricio, et al.
Publicado: (2012)

TCR repertoire landscape reveals macrophage-mediated clone deletion in endotoxin tolerance
por: Zhao, Juanjuan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ve5ocd00ld6a1sk40feat345h7